DNA Brands, Inc.
DNAX · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $2 | $30 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3 | $3 | $2 | $2 |
| Enterprise Value | $4 | $3 | $4 | $32 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | 99.2% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | -65.3% |
| Net Income | -$1 | -$1 | -$0 | -$0 |
| % Margin | – | – | – | -66.2% |
| EPS Diluted | -0 | -0.001 | -0.001 | -0.001 |
| % Growth | 80% | -42.9% | -16.7% | – |
| Operating Cash Flow | -$0 | – | -$0 | -$0 |
| Capital Expenditures | -$0 | – | $0 | -$0 |
| Free Cash Flow | -$0 | – | -$0 | -$0 |